MDWD MediWound Ltd. Insider Trading

Director Nachum Shamir buys 6,000 shares at $14.00 blended avg; 3rd insider purchase in 14 days

Nachum Shamir, a director at MediWound Ltd., executed 2 separate purchases totaling 6,000 shares (6.0K shares) for $83,995.63 ($84.0K) on 2026-06-03, at a blended average price of $14.00. This purchase increases his holdings by 12.0% from 49,815 shares to 55,815 shares. The transaction is part of a cluster pattern in which 2 other insiders have also purchased within the past 14 days. Stock price context shows the current price of $14.45 is -35.8% from the 52-week high of $22.50 and has declined 17.1% over the past 30 days. Synchronized buying by multiple insiders during a period of significant price weakness may indicate management confidence in intrinsic value at current levels, though the stock remains in a downtrend both short-term (30-day: -17.1%) and medium-term (90-day: -15.2%).

Director David Morton Fox purchases 3,537 shares at $14.11 avg; holdings rise 18.9% to 22,283 shares

David Morton Fox, a Director at MediWound Ltd., executed 3 separate purchases totaling 3,537 shares for $49,900.57 on 2026-06-01 at a blended average price of $14.11. His post-transaction holdings increased to 22,283 shares, representing an 18.9% increase from his pre-transaction base of 18,746 shares. The current stock price is $13.82, placing the company 38.6% below its 52-week high of $22.50 and down 19.6% over the past 90 days, providing context for the purchase. The transaction's relevance to investors lies in observing the director's capital allocation during a period of sustained price decline, though the Form 4 filing itself does not disclose the director's stated rationale or any non-public information that may have motivated this acquisition.